Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
NICE approves idebenone for treatment of Leber’s hereditary optic neuropathy
Published on August 14, 2025
The announcement is the first time a treatment for a mitochondrial disease has been approved for use on the NHS in England
Continue reading on website
Other news
The National Optometric Association: Looking back to move forward
August 14, 2025
Sherrol A. Reynolds, OD, FAAO, details how NOA's history impacts its vision for the future.
BostonSight expands clinical trials capabilities for optometric and ophthalmic research
August 14, 2025
With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.
NICE approves idebenone for treatment of Leber’s hereditary optic neuropathy | Edcetera - Optometry